Loading...

Avacta Group Plc

AVCTF•PNK
Healthcare
Biotechnology
$0.97
$0.00(0.00%)
U.S. Market opens in 16h 31m

Avacta Group Plc (AVCTF) Stock Overview

Explore Avacta Group Plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap425M
P/E Ratio-15.39
EPS (TTM)$-0.15
ROE-3.76%
Fundamental Analysis

AI Price Forecasts

1 Month$0.88
3 Months$0.81
1 Year Target$0.63

AVCTF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Avacta Group Plc (AVCTF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.02, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.39 and a market capitalization of 425M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
12.05%
3-Month Change
25.59%
6-Month Change
-7.47%
Year-to-Date (YTD) Change
24.89%
1-Year Change
86.85%
3-Year Change
-22.27%
5-Year Change
-72.24%
All-Time (Max) Change
-58.87%

Contact Information

https://www.avacta.com
44 1904 217 070
Thorp Arch Estate, Wetherby, NaN, LS23 7FA

Company Facts

154 Employees
IPO DateMay 22, 2020
CountryGB
Actively Trading

Frequently Asked Questions